“Medigrowth’s team is committed to investing in multi disciplinary research and development efforts with leading research institutions and governing bodies across Australia,” said Tyler Robson, CEO, Valens GroWorks. In signing this letter of intent with Medigrowth, Valens secures a three-year supply partnership in the Australian market while strategically aligning ourselves with a company that shares in our commitment to innovation and premium product offerings to enhance patient care.
Deakin has five campuses, five research institutes and eleven strategic research centres. Deakin University is solving global challenges and making a positive impact on the world. World class Research and Development capabilities at Deakin offer Medigrowth expertise and collaboration opportunity across a range of sectors including health, science, engineering, agriculture & technology with a clear commercialisation focus.
Compass Lifestyle Clinics provides comprehensive advice in an environment where doctors and allied health professionals can work together to help patients achieve optimum health and function.
As part of holistic health, Compass is supportive of medicinal cannabis, with the goal of integrating this important therapeutic agent into modern medicine.
“Providing high standards of care and guiding patients on their road to better health is our ultimate goal”
A subsidiary of Medigrowth Australia, Medigrowth New Zealand will further consolidate the Medigrowth commitment to research and development; ensuring domestic patients have access to safe, trusted and affordable locally grown medicinal cannabis.
Pharmout is a specialist medical device and pharmaceutical consultancy. Experts in Good Manufacturing Practice (cGMP), the team at Pharmout have been instrumental in design of the planned Medigrowth Centre of Excellence, ensuring GMP compliance and (QA) Quality Assurance across all sectors of our ‘Hybrid Grow’ cultivation, manufacturing, laboratory and research operations.
The Medical Cannabis Council is comprised of organisations and individuals from across the supply chain. Membership signals our commitment to the industry as a whole, and a commitment to the collective industry’s push to advance our support for Australian patients. Involvement in the council ensures opportunity for Medigrowth to help shape our industry’s future via the Councils advocacy for government policies.
Established by the truly inspirational Lucy Haslam, United in Compassion states its primary mission as “advocating for patient access to Full Spectrum herbal medicinal cannabis extracts and dried herb cannabis; in a manner which is safe, effective, affordable, equitable and favourable for patients, for the dignified relief of suffering.” Medigrowth Australia is passionate in its commitment to provide pure, safe and trusted Australian grown cannabinoid medicines for delivery to Australian patients and will continue to support endeavours to improve patient access and outcomes.
For more information regarding our business, our products and services or any general corporate enquiry, please get in touch.
© Copyright 2019 Medigrowth Australia Pty Ltd.